Public Citizen Files Lawsuit To Get FDA to Add Impulse Control Warning Added To Requip, Similar Parkinson’s Disease Drugs
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Abilify Lawsuit Alleges Side Effects Caused Compulsive Gambling Problems January 14, 2016 Irvin Jackson Add Your Comments According to allegations raised in a recently filed product liability lawsuit side effects of Abilify caused a Minnesota woman to compulsively gamble, racking up losses in excess of $75,000 and causing her family to suffer serious financial problems. In a complaint (PDF) filed in the U.S. District Court for the District of Minnesota on January 12, Denise Miley indicates that she began to have uncontrollable urges to gamble after she began using the atypical antipsychotic. While the compulsive behavior ended when she was removed from the medication, Miley and her husband indicate that they suffered substantial damages, resulting in loss of financial stability, as well as other mental, physical and economic damages. Learn More About Abilify Lawsuits Side Effects of Abilify May Increase the Risk of Compulsive Gambling, Shopping and Other Addictive Behaviors Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Abilify Lawsuits Side Effects of Abilify May Increase the Risk of Compulsive Gambling, Shopping and Other Addictive Behaviors Learn More SEE IF YOU QUALIFY FOR COMPENSATION The lawsuit names Bristol-Myers Squibb and Otsuka Pharmaceutical Co. as defendants, arguing that the drug makers knew or should have known about the link between Abilify and gambling, yet failed to provide adequate warnings for consumers or the medical community about the importance of monitoring for signs of compulsive behaviors while using the drug. Miley notes in the complaint that from May 1, 2009 through May 1, 2011, the FDA received nearly 4,600 adverse event reports regarding Abilify, of which more than two thousand were considered serious. From 2005 through 2013, the agency logged at least 54 reports of compulsive or impulsive behavior problems linked to Abilify, 30 of which involved gambling, 12 involving impulsive behavior, nine involving hypersexuality, and three reports of compulsive shopping. “Abilify is a partial and full dopamine agonist. Dopamine is a neurotransmitter that helps control the brain’s reward and pleasure centers,” the lawsuit states. “Dopamine’s role in compulsive behavior and pathelogical gambling is well-known. Dopaminergic reward pathways have frequently been implicated in the etiology of addictive behavior. Scientific literature has identified dopamine as a potential cause of pathological gambling for years.” The lawsuit notes that in Europe and Canada, Abilify warning labels are required to mention the risk of compulsive gambling, promiscuity and other self-destructive behaviors. However, the manufacturer has not placed the word gambling on labels in the U.S. Abilify Gambling Problems Abilify (ariprazole) is the most widely used medication of those evaluated by the researchers, which was introduced in 2002 for treatment of schizophrenia, bipolar disorder and other major depressive disorders. The medication has also been widely used to treat irritability, aggression, mood swings and other behavior issues. Amid aggressive marketing that has promoted Abilify as safe and effective, the medication has grown to become a top-selling brand name drug in the United States, generating sales of nearly $6.5 billion in 2013. A study published in October 2014 in JAMA Internal Medicine found that a class of drugs known as dopamine receptor agonists, often used to treat Parkinson’s disease, were linked to impulse control problems. However, the researchers also saw the same behavioral problems associated with the use of Abilify. Addictive gambling on Abilify can have a severe impact on users, causing severe financial losses and behavior that can destroy families, reputations and cause irreparable damage to an individuals quality of life. A number of other former users have filed similar Abilify gambling lawsuits against the drug’s manufacturers, alleging that if warnings had been provided about the risk of impulsive behaviors, they may have avoided devastating consequences by recognizing the potential side effects associated with the medication. Tags: Abilify, Antipsychotic, Bristol Myers Squibb, Gambling, Otsuka Pharmaceutical Co More Abilify Lawsuit Stories Public Citizen Files Lawsuit To Get FDA to Add Impulse Control Warning Added To Requip, Similar Parkinson’s Disease Drugs May 6, 2019 Settlement for Abilify Gambling Cases To Be Reviewed With Parties and Judge This Week February 19, 2019 Trials for Six “Fast-Tracked” Abilify Gambling Cases Expected To Begin in Summer 2019 December 12, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
Public Citizen Files Lawsuit To Get FDA to Add Impulse Control Warning Added To Requip, Similar Parkinson’s Disease Drugs May 6, 2019
Settlement for Abilify Gambling Cases To Be Reviewed With Parties and Judge This Week February 19, 2019
Trials for Six “Fast-Tracked” Abilify Gambling Cases Expected To Begin in Summer 2019 December 12, 2018
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)